Published in

Wiley, British Journal of Haematology, 6(173), p. 938-940, 2015

DOI: 10.1111/bjh.13644

Links

Tools

Export citation

Search in Google Scholar

Ruxolitinib is an effective treatment for CALR -positive patients with myelofibrosis

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO